Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Pfizer abandons exubera

October 22, 2007

Analysis of:Pfizer Abandons Exubera, Posts 77% Earnings Decline | online.wsj.com

Due to poor sales, Pfizer has decided to pull the plug on Exubera (inhaled insulin). This will have a signficant impact on other companies who are developing other inhaled insulin products.

Diabetes drugs and heart disease

June 11, 2007

Analysis of:U.S. urges strongest warning on 2 diabetes drugs | www.iht.com

The FDA has now mandated a black box warning regarding the risk of heart failure related to the drugs Avandia and Actos (Glaxo Smith Kline and Takeda). This comes after a highly publicized article in the New England Journal of Medicine that assessed the risk of heart disease and death in patients treated with rosiglitazone (Avandia). The recent media coverage and congressional hearing has prompted this warning, and the concern about these prescription drugs will have a significant impact.

Insulin and weight loss

April 29, 2007

Analysis of:New Data Confirm That Use Of Levemir® Can Limit Weight Gain | www.medicalnewstoday.com

This study evaluated a large number of patients treated with Levemir. When patients are started on insulin therapy, one side effect is frequently weight gain. This study demonstrated that Levemir did not result in weight gain, but rather weight loss (small amount).

Page : 11 to 3 of 3

Subscribe to Updates

By RSS